Heart rhythm regulation

Heart rhythm regulation is a complex physiological process that coordinates the electrical impulses and muscular contractions of the heart to maintain efficient systemic circulation. This regulation is primarily governed by the sinoatrial (SA) node, which acts as the natural pacemaker, and is modulated by the autonomic nervous system through a coordinated network of transmembrane proteins [1, 17]. Key molecular components involved in this process include voltage-gated ion channels such as Sodium channel protein type 5 subunit alpha (SCN5A), Potassium voltage-gated channel subfamily H member 2 (KCNH2), and Hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4), alongside Beta-1 adrenergic receptors and intracellular scaffolds like A-kinase anchoring proteins (e.g., AKAP10) [3, 4, 11]. Dysregulation of these pathways leads to cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia, which are significant contributors to global morbidity and mortality [1, 15]. Pharmacological intervention involves antiarrhythmic drugs that target these specific ion channels or receptors to stabilize the cardiac action potential and restore normal sinus rhythm [7, 8]. Because heart rhythm is the emergent property of an integrated molecular network rather than a single molecule, therapeutic strategies often involve multi-target drugs, though these carry risks of proarrhythmia and systemic toxicity [15, 18].

Other names

Cardiac rhythm controlHeart rate modulationCardiac pacemakingRegulation of heart rate (GO:0002027)

Modulation of cardiac electrical activity through the blockade of voltage-gated ion channels (Sodium, Potassium, and Calcium), inhibition of hyperpolarization-activated pacemaker currents (If) via HCN channels, and antagonism of autonomic G protein-coupled receptors (primarily Beta-adrenergic) to regulate the rate and rhythm of myocardial contraction [3, 7, 11, 15].